Low concentration of endocrine-disrupting chemicals (EDCs) may lead to serious consequences in animals and human, so it is essential to develop an effective assay for EDCs detection. In this study, we developed a novel ERα-mediated reporter gene assay based on the LLC-MK2 cells by co-transfecting pERE-sv40-Luc, hERα-pcDNA3.1, and pRL-tk. Then we determined 17β-estradiol (E2) and some estrogenic/antiestrogenic chemicals to verify the validity of this assay. Data showed that the assay possesses a concentration-dependent responses to E2 and diethylstilbestrol (DES) from 10(-12 )M to 10(-8 )M with EC(50) 3.4 × 10(-10 )M and 5.9 × 10(-10 )M, and ICI 182,780 completely blocks the luciferase activity induced by 10(-9 )M E2. Bisphenol A (BPA), nonylphenol (NP), genistein (GS), and tamoxifen (TAM) also showed corresponding estrogenic or antiestrogenic activity at test concentrations. All evidences proved that the LLC-MK2 reporter gene assay was specific and sensitive to estrogen receptor (ER) agonistic and antagonistic chemicals.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: